desipramine has been researched along with Bulimia in 22 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A comparison of cognitive-behavior therapy alone, desipramine alone, and cognitive-behavior therapy combined with desipramine was made in the treatment of bulimia nervosa." | 9.07 | Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. ( Detzer, MJ; Leitenberg, H; Rosen, JC; Srebnik, D; Vara, LS; Wolf, J, 1994) |
| "The cardiovascular effects of desipramine were assessed in 74 young women with bulimia nervosa participating in a 6-week double-blind, placebo-controlled study." | 9.07 | Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa. ( Hadigan, CM; Walsh, BT; Wong, LM, 1992) |
| "Twenty-three women with nonpurging bulimia underwent a 12-week, double-blind, placebo-controlled trial of desipramine hydrochloride." | 9.06 | Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. ( Agras, WS; McCann, UD, 1990) |
| "Desipramine was significantly more effective than placebo in reducing the frequency of weekly binding, weekly vomiting, and the fatigue scale of the POMS." | 6.66 | Treatment of bulimia with desipramine: a double-blind crossover study. ( Barlow, J; Blouin, A; Blouin, J; Perez, E, 1988) |
| "At 1-year follow-up, both the combined 24-week treatment and CBT alone were significantly superior in reducing binge eating to desipramine given for 16 weeks." | 5.07 | One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. ( Agras, WS; Arnow, B; Bruce, B; Koran, LM; Raeburn, SD; Rossiter, EM; Telch, CF, 1994) |
| "A comparison of cognitive-behavior therapy alone, desipramine alone, and cognitive-behavior therapy combined with desipramine was made in the treatment of bulimia nervosa." | 5.07 | Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. ( Detzer, MJ; Leitenberg, H; Rosen, JC; Srebnik, D; Vara, LS; Wolf, J, 1994) |
| "The Personality Disorders Examination (PDE) was administered to 71 bulimia nervosa patients at baseline assessment in a study comparing the effectiveness of cognitive-behavioral treatment with desipramine or the combination of both treatments." | 5.07 | Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa. ( Agras, WS; Rossiter, EM; Schneider, JA; Telch, CF, 1993) |
| "The cardiovascular effects of desipramine were assessed in 74 young women with bulimia nervosa participating in a 6-week double-blind, placebo-controlled study." | 5.07 | Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa. ( Hadigan, CM; Walsh, BT; Wong, LM, 1992) |
| "This study examined the relative effectiveness of desipramine, cognitive-behavioral therapy, and their combination in the treatment of bulimia nervosa, together with the effects of withdrawing medication after two different lengths of treatment." | 5.07 | Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. ( Agras, WS; Arnow, B; Bruce, B; Koran, LM; Perl, M; Raeburn, SD; Rossiter, EM; Schneider, JA; Telch, CF, 1992) |
| "The study documents a beneficial effect of desipramine in the treatment of bulimia nervosa when compared to placebo." | 5.07 | Long-term outcome of antidepressant treatment for bulimia nervosa. ( Devlin, MJ; Gladis, M; Hadigan, CM; Roose, SP; Walsh, BT, 1991) |
| "To determine the value of total serum amylase levels and salivary and pancreatic isoenzyme levels as biologic indices of behavioral disturbance in bulimia nervosa, the authors monitored these levels in 40 bulimic patients participating in a placebo-controlled trial of desipramine and in 25 controls." | 5.06 | Hyperamylasemia in bulimia nervosa. ( Bodourian, SH; Hadigan, CM; Pesce, MA; Walsh, BT; Wong, LM, 1990) |
| "Twenty-three women with nonpurging bulimia underwent a 12-week, double-blind, placebo-controlled trial of desipramine hydrochloride." | 5.06 | Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. ( Agras, WS; McCann, UD, 1990) |
| "We conducted an exploratory post hoc study that compared the cost effectiveness of five treatments for bulimia nervosa: 15 weeks of cognitive behavioral therapy (CB) followed by three monthly sessions, 16 weeks (Med16) and 24 weeks (Med24) of desipramine (< or = 300 mg/day), and CB combined with desipramine for those durations (Combo16 and Combo24)." | 3.69 | Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa. ( Agras, WS; Arnow, B; Bruce, B; Koran, LM; Kraemer, HC; Perl, M; Raeburn, S; Rossiter, EM; Schneider, JA; Telch, CF, 1995) |
| "Although patients with a history of substance abuse reported higher levels of anxiety and depression at presentation for treatment than patients without such histories, the two groups reported a similar age of onset of their bulimia nervosa and similar severity of eating pathology with regards to binge and vomit frequencies and measures of concern about body shape and weight." | 2.67 | The impact of prior substance abuse on treatment outcome for bulimia nervosa. ( Pike, KM; Strasser, TJ; Walsh, BT, 1992) |
| "Desipramine was significantly more effective than placebo in reducing the frequency of weekly binding, weekly vomiting, and the fatigue scale of the POMS." | 2.66 | Treatment of bulimia with desipramine: a double-blind crossover study. ( Barlow, J; Blouin, A; Blouin, J; Perez, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 16 (72.73) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agras, WS | 5 |
| Rossiter, EM | 4 |
| Arnow, B | 3 |
| Telch, CF | 4 |
| Raeburn, SD | 2 |
| Bruce, B | 3 |
| Koran, LM | 3 |
| Leitenberg, H | 1 |
| Rosen, JC | 1 |
| Wolf, J | 1 |
| Vara, LS | 1 |
| Detzer, MJ | 1 |
| Srebnik, D | 1 |
| Walsh, BT | 8 |
| Giardina, EG | 1 |
| Sloan, RP | 1 |
| Greenhill, L | 1 |
| Goldfein, J | 1 |
| Ziff, H | 1 |
| Kominars, K | 1 |
| Wasserman, C | 1 |
| Soucar, E | 1 |
| Schneider, JA | 3 |
| Raeburn, S | 1 |
| Perl, M | 2 |
| Kraemer, HC | 1 |
| Devlin, MJ | 4 |
| Wilson, GT | 2 |
| Loeb, KL | 2 |
| Pike, KM | 2 |
| Roose, SP | 3 |
| Fleiss, J | 1 |
| Waternaux, C | 2 |
| Labouvie, E | 1 |
| Petkova, E | 1 |
| Liu, X | 1 |
| Strasser, TJ | 2 |
| Ames-Frankel, J | 1 |
| Sadik, C | 1 |
| Oldham, JM | 1 |
| Hadigan, CM | 3 |
| Wong, LM | 2 |
| Pesce, MA | 1 |
| Bodourian, SH | 1 |
| Gladis, M | 1 |
| McCann, UD | 1 |
| Blouin, J | 2 |
| Blouin, A | 2 |
| Perez, E | 2 |
| Barlow, J | 2 |
| Mitchell, JE | 1 |
| Pyle, RL | 1 |
| Eckert, ED | 1 |
| Hatsukami, D | 1 |
| Pomeroy, C | 1 |
| Zimmerman, R | 1 |
| Blouin, AG | 1 |
| Blouin, JH | 1 |
| Perez, EL | 1 |
| Bushnik, T | 1 |
| Zuro, C | 1 |
| Mulder, E | 1 |
| Weiss, RD | 1 |
| Hughes, PL | 1 |
| Wells, LA | 1 |
| Cunningham, CJ | 1 |
1 review available for desipramine and Bulimia
| Article | Year |
|---|---|
Assessment and treatment of binge-eating disorder.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Bulimia; Cognitive Behavioral Therapy; Combined Moda | 1996 |
16 trials available for desipramine and Bulimia
| Article | Year |
|---|---|
One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.
Topics: Adolescent; Adult; Aged; Body Weight; Bulimia; Cognitive Behavioral Therapy; Combined Modality Thera | 1994 |
Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Desipramine; Fe | 1994 |
Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Body Image; Borderline Personality Disorder; Bulimia; Cognitive Behavioral Therap | 1993 |
Medication and psychotherapy in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Desipramine; Do | 1997 |
Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change.
Topics: Adolescent; Adult; Antidepressive Agents; Bulimia; Cognitive Behavioral Therapy; Desipramine; Female | 1999 |
The impact of prior substance abuse on treatment outcome for bulimia nervosa.
Topics: Adolescent; Adult; Body Weight; Bulimia; Depressive Disorder; Desipramine; Double-Blind Method; Fema | 1992 |
Personality disorder diagnoses in patients with bulimia nervosa: clinical correlates and changes with treatment.
Topics: Adult; Ambulatory Care; Body Weight; Borderline Personality Disorder; Bulimia; Desipramine; Double-B | 1992 |
Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa.
Topics: Adolescent; Adult; Aging; Bulimia; Desipramine; Dose-Response Relationship, Drug; Double-Blind Metho | 1992 |
Hyperamylasemia in bulimia nervosa.
Topics: Adolescent; Adult; Ambulatory Care; Amylases; Body Weight; Bulimia; Desipramine; Female; Humans; Iso | 1990 |
Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Bulimia; Cognitive Behavioral Therapy; Combined Modality T | 1992 |
Long-term outcome of antidepressant treatment for bulimia nervosa.
Topics: Adult; Bulimia; Desipramine; Double-Blind Method; Female; Follow-Up Studies; Humans; Medical Records | 1991 |
Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study.
Topics: Appetite; Bulimia; Desipramine; Double-Blind Method; Eating; Female; Humans; Hunger; Outcome and Pro | 1990 |
Bulimia: independence of antibulimic and antidepressant properties of desipramine.
Topics: Adult; Bulimia; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dexamethasone; Double-Bl | 1989 |
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa.
Topics: Adolescent; Adult; Antidepressive Agents; Bulimia; Clinical Trials as Topic; Desipramine; Feeding Be | 1989 |
Treatment of bulimia with fenfluramine and desipramine.
Topics: Adolescent; Adult; Body Weight; Bulimia; Clinical Trials as Topic; Depression; Desipramine; Double-B | 1988 |
Treatment of bulimia with desipramine: a double-blind crossover study.
Topics: Adult; Bulimia; Clinical Trials as Topic; Desipramine; Double-Blind Method; Follow-Up Studies; Human | 1988 |
5 other studies available for desipramine and Bulimia
| Article | Year |
|---|---|
Effects of desipramine on autonomic control of the heart.
Topics: Adolescent; Adult; Arousal; Attention Deficit Disorder with Hyperactivity; Autonomic Nervous System; | 1994 |
Pharmacologic and cognitive-behavioral treatment for bulimia nervosa.
Topics: Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Desipramine; Humans; Research Desi | 1993 |
Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Bulimia; Cognitive Behavioral Therapy; Combined | 1995 |
Relapse to cocaine abuse after initiating desipramine treatment.
Topics: Adult; Bulimia; Cocaine; Depressive Disorder; Desipramine; Female; Humans; Male; Recurrence; Substan | 1988 |
The dexamethasone suppression test in bulimia before and after successful treatment with desipramine.
Topics: Adolescent; Adult; Body Weight; Bulimia; Depressive Disorder; Desipramine; Dexamethasone; Female; Hu | 1986 |